Scientists have developed a revolutionary new AI tool which, according to a new study, may become crucial in lung cancer screening and treatment.

The study, published in the journal npj Precision Oncology, explored the capabilities of a new device, developed by a team at Northwestern Medicine. The device is called iSeg, which comes from its ability to perform tumor segmentation (online or mapping tumors). The traditional process of tumor segmentation is complex and poses challenges for doctors. It can also take multiple doctors visits, several scans, and a great deal of time. In one study, manual segmentation required 12 scans and took doctors seven hours to complete the manual tumor........

© Fast Company